@SchaubMD

Radiation Oncologist (#sarcoma and #childhoodcancer) @UWRadOnc @UWMedicine @FHProtonTherapy @FredHutch I Mama of two girls I Tweets are my own

 Seattle, WA
radiationoncology.uw.edu/faculty/stephanie-schaub-md/
Joined November 2018
  • Tweets77
  • Following281
  • Followers306
4Media
StephanieSchaubMD retweeted
Simon Lo@SimonLo2105418810 Jan 2024
Our own @SchaubMD @uwradonc and CNS/ spine legend @SahgalArjun @Sunnybrook @UofTDRO ! Don’t miss this webinar! @joshuapalmermd @Hofstetter_MD @UWNeurosurgery
arjun sahgal@SahgalArjun10 Jan 2024
Please see as webinar on use of carbon fiber hardware in spine oncology. Will be a fun informative webinar Feb 13
1
4
7
1,560
StephanieSchaubMD retweeted
nwsarcoma@nwsarcoma22 Aug 2023
We want to recognize some of the #SurgicalOncologist that support the #Sarcoma community. Thank you for the work you do! #SurgicalOncologistDay #dragonslayersunite
1
3
5
465
StephanieSchaubMD retweeted
Simon Lo@SimonLo2105418819 Apr 2023
Replying to @uwradonc
@uwradonc @UWNeurosurgery @fredhutch @KristinRedmond2 @hopkinskimmel @ANViswanathanMD @SchaubMD @DrFehlings @uoftmedicine @MSK_RadOnc
Neurosurgery - TU Munich@NCH_TUM18 Apr 2023
Radiotherapy for Mobile Spine and Sacral Chordoma: A Critical Review and Practical Guide from the Spine Tumor Academy mdpi.com/2252966 #mdpicancers via @Cancers_MDPI

Radiotherapy for Mobile Spine and Sacral Chordoma: A Critical Review and Practical Guide from the...

Chordomas are rare tumors of the embryologic spinal cord remnant. They are locally aggressive and typically managed with surgery and either adjuvant or neoadjuvant radiation therapy. However, there...

mdpi.com
3
2
260
StephanieSchaubMD retweeted
PDBrown
@PDBrownOnc17 Jan 2023
Interesting study from #MDACC I use this regimen for radioresistant osseous #metastases too extensive for #spine #SBRT #IMRT #roedu #radonc sciencedirect.com/science/ar…
3
18
1
60
4,666
StephanieSchaubMD retweeted
Lara Davis, MD@DrLaraDavis15 Jan 2023
Important perspectives Maybe this is something @nwsarcoma and @OHSUKnight and @fredhutch can parter on: improving our efforts to include #sarcoma patient perspectives in our research
SPAGN@sarcomapatients14 Jan 2023
What is the rationale behind patient involvement in clinical research? Read our latest blog post: bit.ly/3k2abqr #sarcoma #GIST #bonesarcoma #desmoid #voicesofsarcoma #blog #makeyourvoiceheard #patientinvolvement @Amocras
2
7
830
StephanieSchaubMD retweeted
nwsarcoma@nwsarcoma15 Dec 2022
Thurs, Jan. 26, learn about Proton Therapy by Dr. Stephanie Schaub with @fredhutch and how it may be used as a form of targeted radiation therapy for Sarcoma patients. #nwsarcoma, #dragonslayersunite, #fredhutch
1
4
12
StephanieSchaubMD retweeted
Michael Wagner@wagsmd23 Nov 2022
Nearly All Oncology Providers Report Prior Authorization Causing Delayed Care, Other Patient Harms | ASCO old-prod.asco.org/news-initi…
3
1
12
StephanieSchaubMD retweeted
Lia Halasz MD@LiaHalaszMD8 Nov 2022
Just a fraction of the #wewhocurie in our department @uwradonc @fredhutch Honored to work with @ebadimary1 @havard_molly @SchaubMD @ErinGillespieMD @VictoriaNoelleB @WomanPhysicist @JingZeng98195 @SaraZakem @EmilyWegMD and many others!
7
33
Effective hypofractionated radiation (42.75 Gy in 15 frac) for treatment of soft tissue sarcomas. Congrats to ⁦⁦⁦@ashleighg⁩ and ⁦@MDAndersonNews⁩ #radonc colleagues. #ASTRO22 #endcancer
14
1
58
StephanieSchaubMD retweeted
Michael Wagner@wagsmd12 Oct 2022
Replying to @fredhutch
And we’re hiring in sarcoma (and other cancer types)! Exciting opportunities to advance cancer treatment and improve lives for patients here in Seattle.
1
5
#ChildhoodCancerAwarenessMonth, we're highlighting a #pediatric #radonc study on mutational burden in #EwingSarcoma by @DHaasKogan @kevinxliu @NayanLamba @DrWilliamHwang @BrighamRadOnc @DFBC_PedCare @HarvardRadOnc Check out their work at acsjournals.onlinelibrary.wi… #GoGoldForKids 🎗️

Risk stratification by somatic mutation burden in Ewing sarcoma

Higher somatic mutation counts in patients with localized Ewing sarcoma are correlated with worse overall survival and time to progression and likely are independent from global genomic instability....

acsjournals.onlinelibrary.wiley.com
2
3
Beautiful morning to dragon slay. #NWSarcomaFoundation walk. Thank you for all that you do to support our patients!
1
11
StephanieSchaubMD retweeted
marta scorsetti@MartaScorsetti9 Sep 2022
SBRT for oligometastatic sarcoma: results from our phase II trial confirming high rates of LC with negligible toxicity. sciencedirect.com/science/ar…
2
26
1
79
This is so important, particularly as a provider caring for rare diseases. nejm.org/doi/full/10.1056/NE…
1
2
StephanieSchaubMD retweeted
Michael Wagner@wagsmd24 Aug 2022
West Coast Sarcoma Conference in Seattle this weekend! ⁦Looking forward to good discussions about #sarcoma science and advances @fredhutch⁩ ⁦@SeattleCCA⁩ ⁦@UWMedicine⁩
3
4
1
52
StephanieSchaubMD retweeted
Simon Lo@SimonLo2105418816 Jul 2022
Replying to @uwradonc
@uwradonc @IUradonc @RadoncUh @BeaumontRadOnc @QueensRadOnc @Sunnybrook @PeterMacRadOnc @AncaGrosu1 @CZamboglou @SE_Combs @KristinRedmond2 @MayoRadOnc @KenOlivierMD @DrStish @_ShankarSiva @TimkWin @emmadunne @matt_footy @subatomicdoc @SchaubMD
Matthias Guckenberger@Mat_Guc16 Jul 2022
SBRT for long bone mets - 111 pts 114 mets - 84 femur, 26 humerus, 4 tibia - most common doses 30-50 Gy in 5Fx 👉 2a fracture: 6.1% 👉 2a local failure: 7.2% 👉 extraosseous disease sig. associated with fracture & local failure 👍THX to all collaborators! sciencedirect.com/science/ar…
2
12
StephanieSchaubMD retweeted
Binaytara
@binaytara27 May 2022
This article from our @BTFjournal discusses sarcoma specific considerations for academic-community partnerships across the cancer care spectrum and how these relationships have been impacted by the COVID-19 pandemic. @wagsmd @SchaubMD journal.binayfoundation.org/…
4
5
It's a #Match2022!! We are thrilled to announce that Drs. Liu & Yeh will be joining our exceptional team of residents at @uwradonc. #futureleaders #radonc
1
2
1
27
Load more